Patent assignee · US · COMPANY

AskAt Inc.

14Patents
14Active
14Granted
50Portfolio score

Filing activity: Jan 6, 2014 → Apr 2, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US9447066B2 Salts and crystal forms Chemistry; Metallurgy 7 Active
US10611761B2 Selective EP4 receptor antagonistic substance for treatment of cancer Chemistry; Metallurgy 4 Active
US9688674B2 Selective EP4 receptor antagonistic substance for treatment of cancer Chemistry; Metallurgy 4 Active
US10391086B2 Use of EP4 receptor antagonists in the treatment of cartilage disease Human Necessities 2 Active
US10947235B2 Selective EP4 receptor antagonistic substance for treatment of cancer Chemistry; Metallurgy 2 Active
US10342785B2 Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer Human Necessities 2 Active
US10973834B2 EP4 inhibitors and use thereof Chemistry; Metallurgy 2 Active
US10583129B2 Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer Human Necessities 2 Active
US9561210B2 Therapeutic agent for ocular disease Chemistry; Metallurgy 0 Active
US12295962B2 Polymorphic compounds and uses thereof Chemistry; Metallurgy 0 Active
US11555023B2 Process for the differential solubility-driven asymmetric transformation of substituted 2H-chromene-3-carboxylic acids Chemistry; Metallurgy 0 Active
US10786490B2 Use of EP4 receptor antagonists in the treatment of cartilage disease Chemistry; Metallurgy 0 Active
US11964963B2 Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol Emerging Cross-Sectional Technologies 0 Active
US11840530B2 Selective EP4 receptor antagonistic substance for treatment of cancer Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.